The Nomogram supports our hypothesis that CBX3 expression and T-stage together have an effect on the OS prognosis of HCC, that CBX3 has a significantly bigger effect on HCC than T-stage, and that CBX3 will function as an independent prognostic biomarker for HCC. Here, CBX3 is linked to hepatocellular carcinoma.